{
    "2019-01-24": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Stocks waver again as chipmakers jump and drug companies dip",
                "features": {
                    "keywords": [
                        "chipmakers",
                        "jump",
                        "drug companies",
                        "dip"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Moderna's Hot New mRNA Technology Has Competition",
                "features": {
                    "keywords": [
                        "Moderna",
                        "mRNA",
                        "competition"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Cost on the rise: Congress to investigate Big Pharma",
                "features": {
                    "keywords": [
                        "cost",
                        "rise",
                        "Congress",
                        "Big Pharma"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Stocks waver as chipmakers power tech company rally",
                "features": {
                    "keywords": [
                        "stocks",
                        "waver",
                        "chipmakers",
                        "tech",
                        "rally"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Healthcare ETFs in Focus Ahead of Q4 Earnings",
                "features": {
                    "keywords": [
                        "healthcare",
                        "ETFs",
                        "Q4",
                        "earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q4",
                        "earnings"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Skyrocketing health care costs key topic at Davos",
                "features": {
                    "keywords": [
                        "health care",
                        "costs",
                        "Davos"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Dow Movers: PFE, INTC",
                "features": {
                    "keywords": [
                        "Dow",
                        "movers",
                        "PFE",
                        "INTC"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Health Care Sector Update for 01/24/2019: URGN, BMY, TTNP, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "URGN",
                        "BMY",
                        "TTNP",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Pfizer Falls 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Falls"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "[$$] The London Report: Vodafone slides after weak S Africa results",
                "features": {
                    "keywords": [
                        "London",
                        "Report",
                        "Vodafone",
                        "slides",
                        "weak",
                        "S Africa",
                        "results"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "telecommunications"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}